Analyst Recommendations

Oppenheimer analyst issues OUTPERFORM recommendation for GWW on February 4, 2026 01:31PM ET. The previous analyst recommendation was Outperform.GWW was trading at $1155 at issue of the analyst...

February 4, 2026   GWW -0.69%

RBC Capital analyst issues OUTPERFORM recommendation for J on February 4, 2026 01:35PM ET. The previous analyst recommendation was Outperform.J was trading at $132.91 at issue of the...

February 4, 2026   J -1.35%

Lake Street analyst issues BUY recommendation for TATT on February 4, 2026 01:43PM ET. The previous analyst recommendation was Buy.TATT was trading at $48.72 at issue of the...

February 4, 2026   TATT -0.83%

RBC Capital analyst issues OUTPERFORM recommendation for EPD on February 4, 2026 01:44PM ET. The previous analyst recommendation was Outperform.EPD was trading at $34.63 at issue of the...

February 4, 2026   EPD 1.09%

RBC Capital analyst issues OUTPERFORM recommendation for EMR on February 4, 2026 01:45PM ET. The previous analyst recommendation was Outperform.EMR was trading at $152.1 at issue of the...

February 4, 2026   EMR 0.05%

Cowen & Co. analyst issues BUY recommendation for CPRI on February 4, 2026 01:44PM ET. The previous analyst recommendation was Buy.CPRI was trading at $20.08 at issue of...

February 4, 2026   CPRI 1.50%

Cowen & Co. analyst issues BUY recommendation for MDLZ on February 4, 2026 01:45PM ET. The previous analyst recommendation was Buy.MDLZ was trading at $59.47 at issue of...

February 4, 2026   MDLZ 0.99%

Wolfe Research analyst issues OUTPERFORM recommendation for FN on February 4, 2026 01:46PM ET. The previous analyst recommendation was Peer Perform.FN was trading at $448.53 at issue of...

February 4, 2026   FN -1.76%

Cowen & Co. analyst issues HOLD recommendation for EPD on February 4, 2026 01:51PM ET. The previous analyst recommendation was Hold.EPD was trading at $34.63 at issue of...

February 4, 2026   EPD 1.09%

Lake Street analyst issues BUY recommendation for CDRE on February 4, 2026 01:50PM ET. The previous analyst recommendation was Buy.CDRE was trading at $42 at issue of the...

February 4, 2026   CDRE -0.45%